Evotec Se Adr Stock Analysis

EVO Stock  USD 5.23  2.42  31.63%   
Evotec SE ADR is undervalued with Real Value of 8.49 and Target Price of 17.6. The main objective of Evotec SE stock analysis is to determine its intrinsic value, which is an estimate of what Evotec SE ADR is worth, separate from its market price. There are two main types of Evotec SE's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Evotec SE's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Evotec SE's stock to identify patterns and trends that may indicate its future price movements.
The Evotec SE stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Evotec SE is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Evotec Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Evotec SE's ongoing operational relationships across important fundamental and technical indicators.
  
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Evotec SE ADR. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.

Evotec Stock Analysis Notes

The book value of the company was currently reported as 6.45. The company has Price/Earnings (P/E) ratio of 444.0. Evotec SE ADR recorded a loss per share of 0.28. The entity last dividend was issued on the 12th of December 2018. The firm had 4:1 split on the 20th of October 2021. Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. Evotec SE was incorporated in 1993 and is headquartered in Hamburg, Germany. Evotec Se operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 4715 people. To learn more about Evotec SE ADR call Mark Finlay at 49 40 560 81 0 or check out https://www.evotec.com.

Evotec SE ADR Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Evotec SE's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Evotec SE ADR or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Evotec SE ADR generated a negative expected return over the last 90 days
Evotec SE ADR has high historical volatility and very poor performance
The company reported the last year's revenue of 820.8 M. Reported Net Loss for the year was (94.98 M) with profit before taxes, overhead, and interest of 151.54 M.
Evotec SE ADR has about 823.67 M in cash with (18.34 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.33.
Evotec SE ADR has a poor financial position based on the latest SEC disclosures
Latest headline from finance.yahoo.com: Zenni Optical Announces Partnership with Evo

Evotec SE ADR Upcoming and Recent Events

Earnings reports are used by Evotec SE to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Evotec SE previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
8th of November 2023
Upcoming Quarterly Report
View
30th of September 2023
Next Fiscal Quarter End
View
30th of June 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Evotec Largest EPS Surprises

Earnings surprises can significantly impact Evotec SE's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2023-11-08
2023-09-30-0.05-0.12-0.07140 
2022-08-11
2022-06-300.03-0.08-0.11366 
2021-12-31
2021-12-310.06-0.11-0.17283 
View All Earnings Estimates

Evotec Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Evotec SE is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Evotec SE ADR backward and forwards among themselves. Evotec SE's institutional investor refers to the entity that pools money to purchase Evotec SE's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Bank Of America Corp2023-12-31
5.7 K
Fmr Inc2023-12-31
K
Ubs Group Ag2023-12-31
2.3 K
Quadrant Capital Group Llc2023-12-31
2.1 K
U.s. Bancorp2023-12-31
1.2 K
Signaturefd, Llc2023-12-31
994
Hhm Wealth Advisors, Llc2023-12-31
450
Gamma Investing Llc2023-12-31
285
First Manhattan Co. Llc2023-12-31
225
Mubadala Investment Company Pjsc2023-12-31
4.6 M
Federated Hermes Inc2023-12-31
576.9 K
Note, although Evotec SE's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Evotec Market Capitalization

The company currently falls under 'Mid-Cap' category with a total capitalization of 2.71 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Evotec SE's market, we take the total number of its shares issued and multiply it by Evotec SE's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Evotec Profitablity

Evotec SE's profitability indicators refer to fundamental financial ratios that showcase Evotec SE's ability to generate income relative to its revenue or operating costs. If, let's say, Evotec SE is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Evotec SE's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Evotec SE's profitability requires more research than a typical breakdown of Evotec SE's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Net Profit Margin of (0.12) %, which means that it does not effectively control expenditures or properly executes on its pricing strategies. This is way below average. In the same way, it shows Net Operating Margin of (0.06) %, which entails that for every $100 of revenue, it lost $0.06.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.08)(0.08)
Return On Capital Employed 0.01  0.01 
Return On Assets(0.07)(0.07)
Return On Equity(0.13)(0.14)

Management Efficiency

As of the 25th of April 2024, Return On Capital Employed is likely to grow to 0.01, while Return On Tangible Assets are likely to drop (0.08). At this time, Evotec SE's Fixed Asset Turnover is very stable compared to the past year. Evotec SE's management efficiency ratios could be used to measure how well Evotec SE manages its routine affairs as well as how well it operates its assets and liabilities.
Last ReportedProjected for Next Year
Book Value Per Share 7.73  9.78 
Net Current Asset Value50.7 M34.1 M
Tangible Asset Value39.4 M32.7 M
Tangible Book Value Per Share 5.78  5.49 
Enterprise Value Over EBITDA 13.68  14.36 
Price Book Value Ratio 1.02  1.69 
Enterprise Value Multiple 13.68  14.36 
Price Fair Value 1.02  1.69 
Enterprise Value1.3 B1.4 B
The analysis of Evotec SE's management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Evotec SE's future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Evotec Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Beta
1.105

Technical Drivers

As of the 25th of April, Evotec SE shows the Standard Deviation of 2.71, variance of 7.32, and Mean Deviation of 2.07. Evotec SE ADR technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to interpolate and analyze data for thirteen technical drivers for Evotec SE ADR, which can be compared to its peers. Please confirm Evotec SE ADR variance and potential upside to decide if Evotec SE ADR is priced favorably, providing market reflects its regular price of 5.23 per share. Given that Evotec SE has information ratio of (0.04), we urge you to verify Evotec SE ADR's prevailing market performance to make sure the company can sustain itself at a future point.

Evotec SE ADR Price Movement Analysis

Execute Study
The output start index for this execution was nine with a total number of output elements of fifty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Evotec SE middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Evotec SE ADR. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Evotec SE ADR Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Evotec SE insiders, such as employees or executives, is commonly permitted as long as it does not rely on Evotec SE's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Evotec SE insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Evotec SE Predictive Daily Indicators

Evotec SE intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Evotec SE stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Evotec SE Corporate Filings

6K
24th of April 2024
A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges.
ViewVerify
6K
23rd of April 2024
A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges.
ViewVerify
6K
8th of April 2024
A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges.
ViewVerify
13A
14th of February 2024
An amended filing to the original Schedule 13G
ViewVerify
6K
3rd of January 2024
A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges.
ViewVerify
6K
8th of November 2023
A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges.
ViewVerify
6K
29th of August 2023
A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges.
ViewVerify
6K
27th of July 2023
A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges.
ViewVerify

Evotec SE Forecast Models

Evotec SE's time-series forecasting models are one of many Evotec SE's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Evotec SE's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Evotec Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Evotec SE prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Evotec shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Evotec SE. By using and applying Evotec Stock analysis, traders can create a robust methodology for identifying Evotec entry and exit points for their positions.
Last ReportedProjected for Next Year
Pretax Profit Margin(0.18)(0.19)
Operating Profit Margin 0.01  0.02 
Net Loss(0.21)(0.22)
Gross Profit Margin 0.27  0.36 

Current Evotec Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Evotec analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Evotec analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
17.6Buy5Odds
Evotec SE ADR current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Evotec analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Evotec stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Evotec SE ADR, talking to its executives and customers, or listening to Evotec conference calls.
Evotec Analyst Advice Details

Evotec Stock Analysis Indicators

Evotec SE ADR stock analysis indicators help investors evaluate how Evotec SE stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Evotec SE shares will generate the highest return on investment. By understating and applying Evotec SE stock analysis, traders can identify Evotec SE position entry and exit signals to maximize returns.
Begin Period Cash Flow463.9 M
Long Term Debt328.3 M
Common Stock Shares Outstanding176.7 M
Total Stockholder Equity1.2 B
Property Plant And Equipment Net650.2 M
Cash And Short Term Investments730 M
Cash415.2 M
Accounts Payable97.3 M
Net Debt91.5 M
50 Day M A7.3696
Total Current Liabilities337.7 M
Other Operating Expenses813.9 M
Non Current Assets Total1.2 B
Forward Price Earnings64.9351
Non Currrent Assets Other74.1 M
When determining whether Evotec SE ADR offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Evotec SE's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Evotec Se Adr Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Evotec Se Adr Stock:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Evotec SE ADR. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.
You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Complementary Tools for Evotec Stock analysis

When running Evotec SE's price analysis, check to measure Evotec SE's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evotec SE is operating at the current time. Most of Evotec SE's value examination focuses on studying past and present price action to predict the probability of Evotec SE's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evotec SE's price. Additionally, you may evaluate how the addition of Evotec SE to your portfolios can decrease your overall portfolio volatility.
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Is Evotec SE's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Evotec SE. If investors know Evotec will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Evotec SE listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.28)
Revenue Per Share
2.321
Quarterly Revenue Growth
0.129
Return On Assets
0.0017
Return On Equity
(0.08)
The market value of Evotec SE ADR is measured differently than its book value, which is the value of Evotec that is recorded on the company's balance sheet. Investors also form their own opinion of Evotec SE's value that differs from its market value or its book value, called intrinsic value, which is Evotec SE's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Evotec SE's market value can be influenced by many factors that don't directly affect Evotec SE's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Evotec SE's value and its price as these two are different measures arrived at by different means. Investors typically determine if Evotec SE is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Evotec SE's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.